KEQU · Insider Trading

Kewaunee Scientific Corp

Every open-market purchase and sale reported by KEQU officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Form 4 Filings
50
most recent
Open-Market Buys
2
code P
Sales
16
code S
Reporting Insiders
10
current holders
KEQU — Recent Form 4 Transactions (latest 2026-07-02)
FiledInsiderRole TypeSharesValue
2026-07-02 Douglas J. Batdorff SVP, Manufacturing Operations MIXED +991 −$234.18K
2026-07-02 Elizabeth D Phillips SVP, People & Culture MIXED +868 −$209.81K
2026-07-02 Donald T. Gardner III Chief Financial Officer MIXED +5,238 −$580.98K
2026-07-02 Ryan S. Noble SVP, Sales & Marketing Dev MIXED +2,397 −$174.33K
2026-07-02 Thomas David Hull III President & CEO MIXED +21,145 −$1.21M
2026-07-02 Mandar Ranade SVP, IT & Engineering MIXED +3,550 −$133.29K
2026-06-25 Ryan S. Noble SVP, Sales & Marketing Dev A +2,628 deriv. —
2026-06-25 Mandar Ranade SVP, IT & Engineering A +2,635 deriv. —
2026-06-25 Donald T. Gardner III Chief Financial Officer A +5,428 deriv. —
2026-06-25 Thomas David Hull III President & CEO A +15,195 deriv. —
2026-06-25 Douglas J. Batdorff SVP, Manufacturing Operations A +2,717 deriv. —
2026-06-25 Elizabeth D Phillips SVP, People & Culture A +2,466 deriv. —
2026-05-04 John Jette Campbell Director A +2,013 —
2026-05-04 Keith M Gehl Director A +2,013 —
2026-03-27 Margaret B Pyle Director G −2,750 —
2026-01-08 Thomas David Hull III President, CEO Sell −2,177 −$81.64K
2026-01-07 Donald T. Gardner III Chief Financial Officer Sell −2,000 −$75.14K
2026-01-02 Thomas David Hull III President, CEO Sell −658 −$24.79K
2025-12-31 Thomas David Hull III President, CEO Sell −884 −$33.60K
2025-12-23 Thomas David Hull III President, CEO Sell −1,000 −$39.00K
2025-12-17 Thomas David Hull III President, CEO Sell −1,000 −$39.00K
2025-10-10 Donald T. Gardner III Chief Financial Officer Sell −3,000 −$128.28K
2025-10-02 Thomas David Hull III President, CEO Sell −1,000 −$43.09K
2025-10-02 Elizabeth D Phillips VP - Human Resources Sell −6,880 −$297.22K
2025-10-01 Thomas David Hull III President, CEO Sell −1,854 −$80.50K
2025-09-24 Thomas David Hull III President, CEO Sell −1,721 −$75.34K
2025-09-22 Thomas David Hull III President, CEO Sell −1,425 −$65.04K
2025-09-12 John Jette Campbell Director A +690 —
2025-07-30 Margaret B Pyle Director G −325 —
2025-07-28 Donald T. Gardner III Chief Financial Officer Sell −3,000 −$175.78K
2025-07-02 Mandar Ranade VP-Information Technology MIXED +1,668 −$75.73K
2025-07-02 Ryan S. Noble VP-Sales & Marketing-Americas MIXED +2,020 −$54.78K
2025-07-02 Thomas David Hull III President, CEO MIXED +8,647 −$203.20K
2025-07-02 Douglas J. Batdorff VP of Manufacturing Operations MIXED +2,179 −$51.28K
2025-07-02 Elizabeth D Phillips VP - Human Resources MIXED +1,537 −$69.77K
2025-07-02 Donald T. Gardner III Chief Financial Officer MIXED +3,206 −$145.32K
2025-06-27 Ryan S. Noble VP-Sales & Marketing-Americas A +4,380 deriv. —
2025-06-27 Douglas J. Batdorff VP of Manufacturing Operations A +4,528 deriv. —
2025-06-27 Donald T. Gardner III Chief Financial Officer A +9,047 deriv. —
2025-06-27 Elizabeth D Phillips VP - Human Resources A +4,111 deriv. —
2025-06-27 Mandar Ranade VP-Information Technology A +4,392 deriv. —
2025-06-27 Thomas David Hull III President, CEO A +25,328 deriv. —
2025-05-09 John Russell Director A +1,896 —
2025-05-09 Keith M Gehl Director A +1,896 —
2025-05-09 Margaret B Pyle Director A +1,896 —
2025-04-14 Thomas David Hull III President, CEO Sell −1,844 −$59.82K
2025-04-11 Donald T. Gardner III Chief Financial Officer Sell −4,000 −$148.43K
2025-04-07 Keith M Gehl Director Buy +1,000 +$35.00K
2025-03-28 Donald T. Gardner III Chief Financial Officer Sell −3,000 −$120.04K
2025-03-24 Keith M Gehl Director Buy +500 +$22.50K
KEQU — Current Insider Holders
InsiderRole Shares HeldValue
Thomas David Hull III President & CEO 70,388 $2.40M
Margaret B Pyle Director 38,787 $1.32M
John Russell Director 34,396 $1.17M
Donald T. Gardner III Chief Financial Officer 30,829 $1.05M
Keith M Gehl Director 22,409 $764.60K
Ryan S. Noble SVP, Sales & Marketing Dev 21,049 $718.19K
Mandar Ranade SVP, IT & Engineering 16,215 $553.26K
Douglas J. Batdorff SVP, Manufacturing Operations 14,630 $499.18K
Elizabeth D Phillips SVP, People & Culture 9,116 $311.04K
John Jette Campbell Director 2,703 $92.23K
KEQU Insider Trading FAQ
Who are the insiders at KEQU?
10 officers, directors and 10%+ beneficial owners currently report holdings in KEQU via SEC Form 4.
Are KEQU insiders buying or selling?
Across the 50 most recent Form 4 filings for KEQU, 2 were open-market purchases (code P) and 16 were sales (code S). Sales frequently reflect scheduled 10b5-1 plans or tax withholding rather than a view on the stock.
How current is KEQU insider data?
Form 4 must be filed within two business days of the transaction, so this is close to real time. The most recent KEQU filing is dated 2026-07-02.
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the KEQU quote page; the site-wide leaderboard is on the insider transactions hub.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.